| Date |
Report No. |
Title |
| Date Aug. 12, 1994 |
Report No. HEHS-94-200R |
Title
United States General Accounting Offlce WashIngton, D.C. 20548 Health, Education and Human Services Divlslon rn3y/- B-226377 August 12, 1994 The Honorable Henry A. Waxman Chairman, Subcommittee on Health and the Environment Committee on Energy and Commerce House of Representatives Dear Mr. Chairman: As the debate over U.S. health care reform continues, prescription drug prices remain the subject o... |
| Date Aug. 5, 1994 |
Report No. AIMD-94-130 |
Title
United States General Accounting Office GAO
August 1994 Report to the Chairman, Committee on the District of Columbia, House of Representatives PRESCRIPTION I DRUGS Automated Prospective Review Systems Offer Potential Benefits for Medicaid GAOIAIMD-94-130 United St&es General Accounting Office Washington, D.C. 20648 Accounting and Information Management Division B-257257 August 5, 1994 The Honorab... |
| Date Aug. 5, 1994 |
Report No. HEHS-94-194FS |
Title
GAO
August 1994 United States General Accounting Office /LJ?Fz24- Fact Sheet for the Chairman, Subcommittee on Regulation, Business Opportunities, and Technology, Committee on Small Business, House of Representatives MEDICAID Chmges in Best Price for Outpatient Drugs Purchased by HMOs and Hospitals GAO/EEHS-94-194FS 1 Notice: This is a reprint of a GAO r&d United States General Accounting Office W... |
| Date July 27, 1994 |
Report No. T-HEHS-94-213 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 930 a.m., EST Wednesday July 27, 1994 Testimony
Before the Committee on Governmental Affairs United States Senate PRESCRIPTION DRUGS Prices and Regulation in Canada and Europe
Statement of Sarah F. Jaggar Director, Health Financing and Policy Issues Health, Education, and Human Services Division Messrs. Chairmen and Me... |
| Date May 17, 1994 |
Report No. HEHS-94-30 |
Title
Health, Education, and Human Services Division B-251111 May 17,1994 The Honorable David H. Pryor Chairman, Special Committee on Aging United States Senate Dear Mr. Chairman: This report, prepared at your request, examines how other countries regulate prescription drug prices, how those policies affect drug prices, and how they affect pharmaceutical research and development. As arranged with your ... |
| Date Jan. 12, 1994 |
Report No. HEHS-94-29 |
Title
United States General Accounting Office GAO
January 1994 Report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives ’ PRESCRIPTION DRUGS Companies Qpically Charge More in the United States Than in the United Kingdom GAO United States General Accounting Office Washington, D.C. 20648 Human Health, Education, and Services Division ... |
| Date Aug. 2, 1993 |
Report No. T-HRD-93-28 |
Title
United States General Accounting Office 14qG61 - - * Testimony
Before the Subcommitteeon Human Resourcesand IntergovernmentalRelations, Committee on GovernmentOperations House of Representatives
For Releaseon Delivery Expected at 9:30 a.m. Monday August 2,1993 MEDICAID DRUG FRAUD Federal Leadership Needed to Reduce Program Vulnerabilities
Statementof Leslie G. Aronovitz AssociateDirector, Health F... |
| Date Aug. 2, 1993 |
Report No. HRD-93-118 |
Title
GAO
August 1993 Report to Congressional Requesters MEDICAID DRUG FRAUD Federal Leadership Needed to Reduce Program Vulnerabilities GAO United States General Accounting Office Washington, D.C. 20648 Human Resources Division B-246968 August 2,1993 The Honorable Charles Range1 House of Representatives The Honorable Edolphus Towns Chairman, Subcommittee on Human Resources and Intergovernmental Relatio... |
| Date Feb. 22, 1993 |
Report No. T-HRD-93-5 |
Title
United StatesGenerd kmmtinp Office GAO
For Release D&very on Eqwedat 1050 am., EST
Mai&ly Testimony
Before the Subcommitteeon Health and the Environment; Committee on Energy and Commerce, _ House of Representatives PRESCRIPTIONDRUGS CompaniesTypically Charge More in the United States Than in Canada
Statementof Janet L. SWes, Director, Health Financing and Policy Issues, Human ResourcesDivision Fcb... |
| Date Jan. 15, 1993 |
Report No. HRD-93-43 |
Title
MEDICAID Changes in Drug Prices Paid by HMOs and Hospitals Since Enactment of Rebate Provisions .,, --. Y
148334 GAO United States General Accounting OMce Washington, D.C. 20548 Human Resources Division B-245873 January 15, 1993 The Honorable Lloyd Bentsen, Chairman The Honorable Bob Packwood, Ranking Minority Member Committee on Finance United States Senate The Honorable John D. Dingell, Chairman... |
| Date Oct. 29, 1992 |
Report No. HRD-93-17 |
Title
IJnited States General Accounting Office Report to Congressional Requesters Octobt?r 1992 WOMEN’ HEALTH S FDA Needs to Ensure More Study of Gender Differences~ in Prescription Drug Testing, II II
147861 GAO/HRD-93-1’ 7 . United States General Accounting Office Washington, D.C. 20548 Human Resources Division B-243898 October 29,1992 The Honorable Henry A. Waxman Chairman, Subcommittee on Health... |
| Date Sept. 30, 1992 |
Report No. HRD-92-110 |
Title
c
lJnited States General Accounting Office GAO
September 1992 Report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce; House of Representatives PRESCRIPTION DRUGS Companies Q-pieally Charge More in the United States Than in Canada
,- aESTRICTED--Not to be released outside the General Accounting Offke unless specifically approved by the Office of Congres... |
| Date Aug. 24, 1992 |
Report No. HRD-92-128 |
Title
GAO PRl%%?RIPTION DRUGS Changes in Prices for Selected Drugs 147429 RES’rRICTED-Not to. be released outside the General Accounting Office unless specifically approved by the Office of Congressional Relations. 555141, RELEM GAO United States General Accounting Oftlce Washingtan, D.C. 20648 Human Resources Division B-249610 August 24, 1992 The Honorable Byron L. Dorgan House of Representatives The... |
| Date July 29, 1992 |
Report No. T-HRD-92-48 |
Title
United States (ieneral Accounting Office
1 Testimony
Before the Select Committee on Narcotics Abuse and Control. House of Representatives For Release: Delivery on Expectedat IO:(W) a.m. Wtxlnt!sday July 29. 1992 MEDICAID PRESCRIPTION DRUG DIVERSION A Major Problem, But State Approaches Offer Some Promise
Statement of Janet L. Shikles, Director Health Financing and Policy Issues Human Resources Div... |
| Date July 21, 1992 |
Report No. HRD-92-115 |
Title
‘ ‘ V r IJrritttd Stittes General Accounting Office ---- - -.- _- -..-~-~.~~ Report to the Chairman, Subcommittee on Health, Committee on Ways and Means, House of Representatives .uly l!fW PRESCRIPTION MONITORING DRUG States Can Readily Identify Illegal Sales and Use of Controlled Substances .
/
147189 ,- IlllllllRlllll ” . RESTRICTED--Not to be releaped outside the General Accounting Office... |
| Date June 10, 1992 |
Report No. T-HRD-92-38 |
Title
United StatesGeneral Accounting Office GAO
For Rclca.. Testimony
Before the Subcommitteeon Oversight and Investigations Committee on Veterans’ Affairs House of Representatives on Del ivcry
Expcad a?t VA HEALTH CARE Efforts to Improve Pharmacies’ Controls Over Addictive Drugs
Statementof David P. Baine, Director FederalHealth Care Delivery Issues Human ResourcesDivision X:30 a.m. EDT
WdlNXJily.... |
| Date July 22, 1991 |
Report No. PEMD-91-20 |
Title
.Jx~l\, I!)!)1 1 PRESCRIPTION DRUGS Selected Direet-toConsumer Advertising Studies Have Methodological Flaws --. -- . 2 ,,, . . .\ -.-- (;AO/I’ I~MI)-!jl-20 GAO United States General Accounting Office Washington, D.C. 20648 Program Evaluation and Methodology Division B-243615
July 22,199l The Honorable John D. Dingell Chairman, Subcommittee on Oversight and Investigations Committee on Energy and... |
| Date July 9, 1991 |
Report No. PEMD-91-19 |
Title
3 c3 cI ^.i _.__. . I^ ._... i^. ._._ . ..- _ ...__I.. .-~..- . ..-._._ - ..--. -_- ._.---...... ..-...-.. ’ GAO Gemeral Accounting OffIce WaUngton, D.C. 20648 Program Evaluation aud Methodology Division unit.4ld states I B-243616 July 9,lQQl The Honorable John D. Dingell Chairman, Subcommitteeon Oversight and Investigations Committee on Energy and Commerce House of Representatives Dear Mr. Chai... |
| Date June 19, 1991 |
Report No. T-HRD-91-36 |
Title
United States General Accounting Office - GAO Testimony For Release on Delivery Expected at 9:00 a.m. Wednesday, June 19, 1991 Controls Over Addictive Drugs in VA Pharmacies Statement of David P. Baine, Director Federal Health Care Delivery Human Resources Division Issues Before the Subcommittee on Oversight and Investigations Committee on Veterans' Affairs House of Representatives GAO/T-HRD-91-36... |
| Date June 6, 1991 |
Report No. HRD-91-101 |
Title
. GA!!!!!!!!’
, i:; .:.,: : GAO United States General Accounting Office Washington, DC 20548 Human Resources Division B-234990 June 6, 1991 The Honorable Lane Evans Chairman, Subcommittee on Oversight and Investigations Committee on Veterans’ Affairs House of Representatives Dear Mr. Chairman: The drug abuse problem in the United States is not limited to the abuse of illegal drugs, such as her... |
| Date July 13, 1989 |
Report No. PEMD-89-26BR |
Title
.,, I’( . ..b ,.1 *,.. *Jnxted States Cietiefai r.kcbuhtmg Uffice~ I ’ Briefing Report to the Chairman, Special Committee on Aging, U.S. Senate July 1989 PRESCRIPTION DRUGS HCFA’s Proposed Drug Utilization Review System Ignores Quality of Care Issues GAO/PEMD-89-26BR -- GAO United States General Accounting Office Washington, D.C. 20548 Program Evaluation and Methodology Division B-235298 Jul... |
| Date May 24, 1989 |
Report No. PEMD-89-18 |
Title
Report to the Chairman, Special Committee on Aging, U.S. Senate May 1989 PRESCRIPTION DRUGS Infomation on Selected Drug Utilization Review Systems GAO/PEMD-89-18 GAO United States General Accounting Office Washington, D.C. 20648 Program Evaluation and Methodology Division B-235483 May 24,1989 The Honorable David Pryor Chairman, Special Committee on Aging United States Senate Dear Mr. Chairman: You... |
| Date Aug. 1, 1988 |
Report No. HRD-88-111 |
Title
United States General Accounting Office GAO
August 1988 Report to the Chakrnan, Select Committee . on Narcotics A&se and Control, House of Representatives CONTROLLED SUBSTANCES Medicaid Data May Be Useful for MonitoringDiversion ~~szaIcTEI)---Not tabe released outsidethe &m?d
Accounting Offke except on the basis of the by the Ofice of Congressional Relations. 5w34aJ
specific approval I I3&7&2 , .-... |
| Date July 16, 1987 |
Report No. PEMD-87-20 |
Title
eL United States General Accounting Office Report to the Chairman, Special Com m ittee on Aging, U.S. Senate July 1987 M E D ICARE Prescription Drug Issues 1, IIIllllll Ill1 III
133702 GAO/PEMD-87-20 1 . ,$ ,. . GAO United States General Accounting Office Washington, D.C. 20648 Program Evaluation and Methodology Division B-227664 July 16, 1987 The Honorable John Melcher Chairman, Special Committee... |
| Date June 2, 1987 |
Report No. T-HRD-87-15 |
Title
United States General Accounting Office I33oW GAO Testimony For Release on Delivery Expected at lo:30 a.m. EDT Tuesday, June 2, 1987 Issues Related of Outpatient Under Medicare to Possible Prescription Coverage Drugs Statement of Michael Zimmerman, Senior Associate Director Human Resources Division Before the Subcommittee on Health Committee on Ways and Means House of Representatives ~llllll Illll... |
| Date Oct. 29, 1982 |
Report No. GGD-83-2 |
Title
BY THECOiPT&LLER GENERAL Report ToThe Congress
OF THEUNITEDSTATES
Comprehensive Approach Needed To Help Control Prescription Drug Abuse
T e abuse of prescription drugs--most of which are o 1:tained at the retail level--results in more injuries and deaths to Americans than all illegal drugs combined. I$ comprehensive approach using law enforcement, regulation, education, and professional peer presi... |
| Date March 8, 1982 |
Report No. HRD-82-37 |
Title
Report To The Secretary Of Health And Human Services - FDA Can Further improve Its Adverse Drug Reaction Reporting System
The Food and Drug Administration has improved the use of its adverse drug reaction reporting system ,since GAO reported on it in 1974. Medical officers are more familiar with ‘the system and are using it more. However, improvements can still be made. Many adverse reaction rep... |
| Date Dec. 31, 1980 |
Report No. HRD-81-36 |
Title
Comptroller General
OF THE UNITED STATES Programs To Control Prescription Drug Costs Under Medicaid~ And Medicare Could Be Strengthened
In August 1976 the Department of Health and Human Services (HHS) put into effect two programs to control the costs of prescription drugs under Medicaid and Medicare. One program--Maximum Allowable Cost (or MAC)--was designed to take advantage of competition in t-h... |
| Date Feb. 20, 1974 |
Report No. 094592 |
Title
UNITED STATES GENERAL ACCOUNTING OFFICE Washington, D.C. 20548 For release on delivery expected at 10 a.m. EDT Wednesday, February 20, 1974 STATEMENT OF ELMER B. STAATS, COMPTROLLER GENERAL OF THE UNITED STATES BEFORE THE MONOPOLY SUBCOMMITTEE SELECT COMMITTEE ON SMALL BUSINESS _ I UNITED STATES SENATE on DIRECT AND INDIRECT EXPENDITURES BY FEDERAL AGENCIES FOR PRESCRIPTION DRUGS We are pleased la... |
| Date May 10, 1972 |
Report No. 094505 |
Title
UNITEDSTATES GENERAL ACCOUNTING OFFICE Washington, D.C. 20548 For release on delivery expected at 10 am. EDT Wednesday, May 10, 1972 STATEMENT OF ELMER STAATS, COMPTROLLER B. GENERAL THE UNITEDSTATES OF BEFORE THE 5‘ s-+Q MONOPOLY SUBCOMMITTEE SELECT COMMITTEE SMALLBUSINESS ON A $+7 UNITED STATES. SENATE fl lG; on
-. EXPENDITURES cDIRECTAND INDIRFCTPRESCRIPTION BY FEDERAL AGENCIES FOR D We are p... |
